131 related articles for article (PubMed ID: 4087696)
1. Norepinephrine-related mechanism in hypertension accompanying renal failure.
Schohn D; Weidmann P; Jahn H; Beretta-Piccoli C
Kidney Int; 1985 Nov; 28(5):814-22. PubMed ID: 4087696
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular counterregulation during sympathetic inhibition in normal subjects and patients with mild hypertension.
Weidmann P; Beretta-Piccoli C; Link L; Bianchetti MG; Boehringer K; Morton JJ
Hypertension; 1983; 5(6):873-80. PubMed ID: 6360870
[TBL] [Abstract][Full Text] [Related]
3. Hypertensive dysregulation and its modification by calcium channel blockade in nonoliguric renal failure.
Weidmann P; Schohn D; Gnädinger MP; Bürgisser E; Ferrier C; Jahn H
Am J Nephrol; 1989; 9(4):269-78. PubMed ID: 2683789
[TBL] [Abstract][Full Text] [Related]
4. Pressor factors and cardiovascular pressor responsiveness in lean and overweight normal or hypertensive subjects.
Boehringer K; Beretta-Piccoli C; Weidmann P; Meier A; Ziegler W
Hypertension; 1982; 4(5):697-702. PubMed ID: 7049922
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular regulation during administration of co-dergocrine to normal subjects.
Gerber A; Weidmann P; Laederach K
Eur J Clin Pharmacol; 1986; 29(5):565-72. PubMed ID: 3956562
[TBL] [Abstract][Full Text] [Related]
6. Association between sympathetic activity and the atherogenic serum cholesterol fraction.
Weidmann P; Schohn DC; Riesen W; Jahn HA; Ferrari P; Shaw SG; Beretta-Piccoli C
Klin Wochenschr; 1990 Mar; 68(5):269-76. PubMed ID: 2182939
[TBL] [Abstract][Full Text] [Related]
7. Potassium and norepinephrine- or angiotensin-mediated pressor control in pre-hypertension.
Bianchetti MG; Weidmann P; Beretta-Piccoli C; Ferrier C
Kidney Int; 1987 Apr; 31(4):956-63. PubMed ID: 3586502
[TBL] [Abstract][Full Text] [Related]
8. Calcium and blood pressure regulation in normal and hypertensive subjects.
Bianchetti MG; Beretta-Piccoli C; Weidmann P; Link L; Boehringer K; Ferrier C; Morton JJ
Hypertension; 1983; 5(4 Pt 2):II57-65. PubMed ID: 6345376
[TBL] [Abstract][Full Text] [Related]
9. Enhanced cardiovascular pressor reactivity to norepinephrine in mild renal parenchymal disease.
Beretta-Piccoli C; Weidmann P; Schiffl H; Cottier C; Reubi FC
Kidney Int; 1982 Sep; 22(3):297-303. PubMed ID: 7176332
[TBL] [Abstract][Full Text] [Related]
10. Renin-angiotensin system in two genetically normotensive strains of Lyon rats.
Lantelme P; Lo M; Sassard J
Am J Hypertens; 2000 Mar; 13(3):283-9. PubMed ID: 10777033
[TBL] [Abstract][Full Text] [Related]
11. Antihypertensive contribution of sodium depletion and the sympathetic axis during chronic angiotensin II converting enzyme inhibition.
Uehlinger DE; Ferrier CP; Matthieu R; Reuter K; Gnaedinger MP; Saxenhofer H; Shaw S; Weidmann P
J Hypertens; 1989 Nov; 7(11):901-7. PubMed ID: 2558135
[TBL] [Abstract][Full Text] [Related]
12. Exaggerated pressor responsiveness to norepinephrine in nonazotemic diabetes mellitus.
Beretta-Piccoli C; Weidmann P
Am J Med; 1981 Nov; 71(5):829-35. PubMed ID: 7304655
[TBL] [Abstract][Full Text] [Related]
13. Effects of acute mild hypercalcemia or of the calcium antagonist nifedipine on cardiovascular responsiveness to norepinephrine or angiotensin II in normal humans.
Beretta-Piccoli C; Bianchetti MG; Weidmann P; Boehringer K; Link L; Morton JJ
J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S306-12. PubMed ID: 6184559
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular and metabolic profile during intervention with urapidil in humans.
Gerber A; Weidmann P; Marone C; Uehlinger D; Riesen W
Hypertension; 1985; 7(6 Pt 1):963-71. PubMed ID: 3908316
[TBL] [Abstract][Full Text] [Related]
15. Antihypertensive mechanism of the diuretic muzolimine in mild renal failure. Roles of sodium and cardiovascular norepinephrine responsiveness.
Schiffl H; Weidmann P; Beretta-Piccoli C; Cottier C; Seiler AJ; Ziegler WH
Eur J Clin Pharmacol; 1982; 23(3):215-20. PubMed ID: 6756933
[TBL] [Abstract][Full Text] [Related]
16. Depressor effects and release of atrial natriuretic peptide during norepinephrine or angiotensin II infusion in man.
Uehlinger DE; Weidmann P; Gnaedinger MP; Shaw S; Lang RE
J Clin Endocrinol Metab; 1986 Sep; 63(3):669-74. PubMed ID: 2942555
[TBL] [Abstract][Full Text] [Related]
17. Body sodium-blood volume state, aldosterone, and cardiovascular responsiveness after calcium entry blockade with nifedipine.
Marone C; Luisoli S; Bomio F; Beretta-Piccoli C; Bianchetti MG; Weidmann P
Kidney Int; 1985 Oct; 28(4):658-65. PubMed ID: 3910913
[TBL] [Abstract][Full Text] [Related]
18. Hypertension secondary to early-stage kidney disease: the pathogenetic role of altered cytosolic calcium (Ca2+) homeostasis of vascular smooth muscle cells.
Schiffl H; Fricke H; Sitter T
Am J Kidney Dis; 1993 May; 21(5 Suppl 2):51-7. PubMed ID: 8494019
[TBL] [Abstract][Full Text] [Related]
19. Blood pressure regulation on low and high sodium diets in normotensive members of normotensive or hypertensive families.
Pusterla C; Beretta-Piccoli C; Städler P; Weidmann P; Favre L; Vallotton M
J Hypertens Suppl; 1986 Dec; 4(6):S310-3. PubMed ID: 3475419
[TBL] [Abstract][Full Text] [Related]
20. Modulation of noradrenergic but not angiotensinergic blood pressure control by beta-blockade with carteolol.
Saxenhofer H; Morger D; Weidmann P; Ferrier C; Shaw SG
J Hypertens; 1991 Nov; 9(11):1049-56. PubMed ID: 1661763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
